Pulmonary Complications After Pediatric Stem Cell Transplant

Area of Science:

• Hematology
• Pulmonology
• Transplantation Medicine

Background:

• Hematopoietic stem cell transplantation (HSCT) is increasingly performed for a wider range of hematologic, genetic, and malignant disorders.
• Pulmonary complications represent a significant cause of morbidity and mortality in HSCT recipients, despite advances in HSCT procedures.
• A clear understanding of pulmonary complication diagnosis and management is crucial for improving patient outcomes.

Purpose of the Study:

• To review current knowledge on pulmonary complications following HSCT.
• To outline diagnostic workup and treatment strategies for various pulmonary complications.
• To identify knowledge gaps and areas for future research, particularly in pediatric populations.

Main Methods:

• Literature review of adult and pediatric studies on pulmonary complications after HSCT.
• Categorization of complications by time of onset (early vs. late) and etiology (infectious vs. non-infectious).
• Synthesis of current diagnostic criteria and treatment guidelines.

Main Results:

• Pulmonary complications in HSCT recipients encompass a broad spectrum of infectious and non-infectious conditions.
• While overall incidence of pulmonary complications has decreased, their severity and impact on mortality persist.
• Infectious complications often have defined diagnostic pathways, whereas non-infectious complications are more complex and less understood.

Conclusions:

• Effective management of HSCT-related pulmonary complications requires a systematic diagnostic approach.
• Further research is needed to elucidate the pathophysiology and optimize treatment for non-infectious pulmonary complications.
• There is a critical need for more pediatric-specific data regarding HSCT-related pulmonary issues.